Optimization of the bioconvertion of the angiotensin I converting enzyme inhibitors IPP and VPP.
Schalk
Jos
J
Unilever Food and Health Research Institute, Olivier van Noortlaan 120, NL-3133 AT, Vlaardingen, The Netherlands.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000378:metabolism / Q000493:pharmacokinetics*; D009842:Oligopeptides / Q000378:metabolism / Q000493:pharmacokinetics*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D013379:Substrate Specificity
D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; C489032:isoleucyl-prolyl-proline; C489031:valyl-prolyl-proline; D007703:Peptidyl-Dipeptidase A